BAT CDC Documents
Some Further Analysis of an Experiment to Compare the Tumour - Promoting Activities of the Condensates From Cigarettes B9 - 1 and B9 - 6
Fields
- Original File
- BATCO002
- URL
- http://outside.cdc.gov/images4/00/02/49/54/doc00001.TIF
- Company
- British American Tobacco
- Date Loaded
- 04 Mar 2003
- Author
- WILKES EB
- Box
- B3177-6
Document Images
IEP01~r NO. ID. 1404 RE~C'IZD
24.8.1976
AUTHOR: R.B. W£1kas
LSSI~.~ lJ~: B.E. W£11£s
PROJECT JOB HO= 11.05.02
DZb'TRZ~L'ZON:
Dr. S.J. Grean Copy Ho. 1
DE. D.G. ¥elCon " " 2, 3
Library I, " 4, 5
COI~N0:
ii i i
BAT Co LTD - MINN~TA TOBACCO LITIGATION
C~

INDEX
HAS
INDICATED
GAP IN
BATES
RANGE
HERE

EBWlLX/46Z>'-2
Group Research & Development Centre,
British-American Tobacco Co. Ltd.,
SO~HA~PTQ~.
2ACh August, 1976
SOb~ FURTI~R ANALYSIS OF AN EXPERIMENT TO
com~J~J[ T~ zz~ou~-zqux~r~c Ac'rzvrrzzs oF
c(x~zz~sx_~zs FZa~"CX~Z'nZ~ zzg/z ~.V' Z9/6
(Report No. RD. Z40A lestrlcted)
SUHHAR¥
This report desc=ibes a stmtlsClc•l amalysls of the data arisln8
from the 3ANUS promoClon experiment cmzpmrlns condensaCes B9/1 end B9/6.
The data were adjusted to simulate r~he situation as if the experLmmnt
had been terminated •t week 32 or 36 or 40 or 44 o= 48 or 52 as well as
the actual teWnLiZmlCiOU time of 57 weeks.
Ic is concluded that doses of 120 US and 180 .1 o£ DH3A as Luitiltor
mrs too h~sh, but ~he opC/=mm dose level cannot be determ£ned. The
60 U8 level of Dt4~A did however yield uae~uI date.
lc is •leo concluded ~hac early tenatnation o£ the experiment may
have been possible uelnS the 60 US DHBA groups, the C~oriSenlc raclo
belng signlflcanc from week ~A onwards.
It is recoemended Chat in future iniCieCor-promotor experimmmts of
t.h:l.s kind at least 80 animals per group should be used, and as a rule
of thumb the experiment should be terminated when the group ehowlng the
lomwC response has • turnout--raCe o£ about 1OZ.
BAT Co LTD - MINNESOTA TOBACCO LITIGATION
o
O4
o~
".--4

2-
L
BAT Co LTD - MINNESOTA TOBACCO LITIGATION
r~
OO

-2-
INTR~DUCTION
An earlier report (I) describes the desiKn of cheexper/ment and
the analysis of the dace when the experiment was terminated. The objective
of this further analysis is to estimate the effect on the s~alysis of
terminating the experiment sooner. The exper~nent actually ended at
week 56. all surviving animals being sacrificed du~iag week 57. Since
the we@ks of occurremca of turnout-bearing animals and else wmek~ of death
of animals dying tumourless are known the data can be adjusted to simulate
the termination of the exper4~mut at any giv@n week, all surviv/ng mnjJnals
be£nK resarded as having been sacrificed dur4~s that week.
THE DATA
The whole a~jpar~mJnc used 34 L~roups o£ mai~als, of .which 24 Kroups
are used in this analysls. These Stoups were subjected to the 24
combinations arising from 2 condensates (Bg/L, B9/6), 4 levels of
application (0, 60, 120, 180 ~S) and 3 condensate dose levels (20, 28.3,
hO ag three t/~ms weekly). :In the oris/~al report Zhe data arm shown
livi~s the incidence of turnout-bearing an/male and the incidence o£
tumourless deaths on a 6-weekly basis. SiJxce durlns the early weeks
of the exper~nmnt the numbers of cumour-baarinK mnJJmls mad the numbers
of cumourlass duths are small it was felt that the er=o=s introduced
by grouping the data into &-week periods would be unacceptably hiKh
and so, for this analysis, the data are used on a 1-~s@k bu£s. (Times
of deaths and t/ross of turnouts are recorded on a week-b~-wmek bmsis.)
Tables 1A r~ 2~A sho~ the data.
METSOD OF ..ANALYSIS
The data were analysed usinK the We£bull distribution function.
Comnon values of the parameters k and w, and separate values 0£ b, were
BAT Co LTD - MINNESOTA TOBACCO LITIGATION

INDEX
HAS
INDICATED
GAP IN
BATES
RANGE
HERE

-3-
fitted Co all 2~ groups by the method of maximum llke~thood. The values
of b, k and w are 8hewn ~n Table 1; these values were obCalned ug£ng ~e
dace as an week 57.
Strictly spaaklng, 4f we ~ro to simulate Ehe analysis of the exper~nc
terminated at var£ous times, then the maximum likelihood values of b, k
and w should be re-asclmated for each elmg-polnt chosen for taz~inmclon.
This procedure would however imvolve a large mmountlnK of co~putlng and
iC was decided co fix the values of k and w arbitrarily and only re-compute
the values of b. 7rou Table I it would seam Chat k - 3.0 azd w - O would
probably fit the data quite well. Table 2 shows the values of b corresponding
to chase values of k and w, ~ Table 3 showB the ~odnema of fie £emt
for the parameters shown in Table 2. From Table 3 it can be seen that
the parameters of Table 2 do indeed fit the data fairly wet1, the value
of X2 - 12.088 wlCh 6 degrees of freedom be~ juaC noC significant
(iC is siEnlflcanC aC the 94Z level of confidence). The mjor contributor
Co chls X2 is Che zroup of animals receiv~ag 39/1, ~0 mE, 120 .8;
as treatment. In this group there were more tw~mar-bearinE animals than
expected in the ~eaks ~ to 47, trich fiver Chan expected 4n Che muccaedlng
10 weeks. In an expar~JnenC eont:a:tu~uK 24 frroups of an/reals, with relaCivaly
few tumour-bemr~ an;,nals in each ~roup, it i8 onlT to be e~rpeeCed Chat
one or Cuo groups may show unuemal patterns of inc£dem:e of fiamour-boar~ng
animals. Thus the degree of lack of fit Lnd£cated by the above value of
X2 is considered Co be acceptable mad the mmalTsis was carried cmC umtJaK
k - 3.0 and w - 0 for all time points.
The dace were analysed aC weeks 32, 36, 40, ~, 48, 52 and 57.
At each of chase c~nm poises values of S mad V for each of the 24 groups
BAT Co LTD - MINNESOTA TOBACCO LITIGATION

BAT Co LTD - MINNESOTA TOBACCO LITIGATION

-4-
were co,~.tad where S - I Dll ~d V - ~ CDIi + ~21> _Cai - V>k. ~ ~ese
expressions DIi ks the number o£ turnout-bear!he animals occurring during
week el, and D2i is the number of tumourleas deaths occurring during
reek t.. Since we have chosen k = 3 and w = 0 we have V- ~ (DIi + D2i) ts.
X
Zt can be shown that the maximum likelihood estimate of the WelbuI1 paramtter
b is the ratio S/V. Thus, at each o£ the time po/Jxts 32, 36, 60, ~, 48,
52 and 57 weeks ~e have available the max/~Jm likelihood values of b, and
the values of S and V, for each of the 24 groups.
RZSULTS OF ANALYSIS
Using the methods dmscribed in (2) and (3), an analysis of variance
was £ormed for each of the time po4ucs. The results are shown in Tables 1B
to 21B. The four levels o£ DHBA pte-tre~taeat (0, 60, 120, 180 ,S) were
treated separately, and at math of the time points, £or each of the DMBA
levels, the Bg/1 to B9/6 tumorigenic ratio (sad its 95Z coufide~ce limits)
were calculated. The data from the 0 D~MA Kroups was /~8ufgiclent to
allow the calculation of the ~umor/~enic ratio (only 2 t~mour-bearing
an/male occurred in these 4 8Taupe); the results o£ this analygi8 of the
data £rou the ocher three l~vel8 of ~(BA pre-tteatmant is shown in
Fisures 1 to 3. These Krephs show plots of the (natural) Iosarithm of
the tumor£Kenic ratio of B9/1 to B9/6 with its 95Z eou£1dence I/wits,
the slope o£ the dose/response curve, and the numbers of tUmOttT--bedLT~
anJJnals, versus time. In order to compute the tumoriSen£c rat£o, a
parallel line regression of In Cb) versus In (condensate dose level)
ks used, the two lines representing the two condensates. Than the
In (tumorigenic ratio) i8 the distlmce between the lines divided by
the slope of the lines; it i8 the slope of these parallel dose-response
BAT Co LTD - MINNESOTA TOBACCO LITIGATION
o
c.,.rl
%.0

INDEX
HAS
INDICATED
GAP IN
BATES
RANGE
HERE
